CLNN
Clene Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website clene.com
- Employees(FY) 75
- ISIN US1856341029
Performance
-4.39%
1W
+19.35%
1M
-19.55%
3M
-19.55%
6M
+24.75%
YTD
-59.78%
1Y
Profile
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. The company's products also include CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease, such as COVID-19 and to provide immune support for symptom resolution. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. The company is headquartered in Salt Lake City, Utah.
Technical Analysis of CLNN 2024-05-10
Overview:
In analyzing the technical indicators for CLNN over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-13 20:00
Clene to Present at Upcoming May Conferences(Globenewswire)
- 2024-05-09 19:30
- 2024-05-08 00:54
- 2024-05-07 20:55
- 2024-05-07 20:00
- 2024-05-07 18:00
- 2024-04-30 20:30
- 2024-04-16 04:01
- 2024-03-18 20:30
- 2024-03-14 20:00
- 2024-03-12 21:30
- 2024-03-12 20:00
- 2024-03-06 19:00
Clene to Present at the 36th Annual ROTH Conference(Globenewswire)
- 2024-02-28 19:00
- 2024-02-21 19:00
- 2024-02-05 01:30
- 2024-01-23 19:30
- 2024-01-09 20:00
- 2024-01-07 18:00
- 2024-01-03 03:25
- 2023-12-22 02:00
Clene Announces New Data from HEALEY ALS Platform Trial(Yahoo Finance)
- 2023-12-20 18:46
- 2023-12-20 18:00
- 2023-12-20 18:00
- 2023-12-18 20:00
- 2023-12-15 02:00
- 2023-12-13 19:36
- 2023-12-11 19:30
- 2023-12-08 01:19
- 2023-11-22 20:00
Page 1 of 4
previousnext